Form 4 for IDXX Idexx Laboratories
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001567619-21-015281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-12 | 2021-08-10 | IDXX | JUNIUS DANIEL M | Dir | M - OptEx | $85.00 | +2,402 | 5,298 | +83% | +$204.2K |
| D | 2021-08-12 | 2021-08-10 | IDXX | JUNIUS DANIEL M | Dir | S - Sale+OE | $679.58 | -2,402 | 2,896 | -45% | -$1.63M |
| D | 2021-08-12 | 2021-08-10 | IDXX | JUNIUS DANIEL M | Dir | M - OptEx | — | -2,402 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | M | A | 2,402 | $85.00 | 5,298 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-10 | S | D | 2,402 | $679.58 | 2,896 | D | — | — | (F1) Represents the weighted average price of the shares sold ranging from a low of $679.47 to a high of $680.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 3 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-08-10 | M | D | 2,402 | — | 0 | D | $85.00 · — to 2026-05-03 | 2,402 Common Stock | (F3) Not applicable. (F2) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders. |